Subscribe to thousands of academic journals for just $40/month
Read and share the articles you need for your research, all in one place.

Reply to the comment on “Atypical retroperitoneal fibrosis associated with biliary stricture: IgG4-related sclerosing disease?” by Matsushita et al.

Details

Publisher
Informa UK Ltd
Copyright
© 2009 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted
Subject
Letters to the Editor
ISSN
0036-5521
eISSN
1502-7708
D.O.I.
10.1080/00365520903159875
Publisher site
See Article on Publisher Site

Preview Only

Expand Tray Hide Tray

Reply to the comment on “Atypical retroperitoneal fibrosis associated with biliary stricture: IgG4-related sclerosing disease?” by Matsushita et al.

Abstract

Scandinavian Journal of Gastroenterology, 2009; 44: 1152 CORRESPONDENCE Reply to the comment on ‘‘Atypical retroperitoneal fibrosis associated with biliary stricture: IgG4-related sclerosing disease?’’ by Matsushita et al. MICHAEL QUANTE1, HUI ZHOU2 & TILMAN SAUERBRUCH1 1 Department of Medicine I and 2Department of Pathology, University Hospital Bonn, Germany TO THE EDITOR: We appreciate the interesting comments made by Matsushita et al. and their reasonable suggestion that autoimmune pancreatitis (AIP) should be considered in the differential diagnoses, as this would require steroid therapy rather than Tamoxifen treatment. This is certainly of interest to all readers. As we mentioned in the case report, we initially considered steroid therapy, as it is recommended for the treatment of retroperitoneal fibrosis. However, owing to our patient having recurrent urinary tract infections, being overweight, and having early signs of osteoporosis, we chose to treat her with Tamoxifen instead. Indeed, together with autoimmune cholangitis, autoimmune pancreatitis could be an alternative diagnosis. Nevertheless, several factors are not consistent with the diagnosis of AIP in our patient. As we discussed in the article, apart from an elevated erythrocyte sedimentation rate (ESR), all laboratory tests were within normal limits. With regard to any autoimmune disease, rheumatoid factor and antibodies
Loading next page...

Preview Only. This article cannot be rented because we do not currently have permission from the publisher.

 
/lp/informa-healthcare/reply-to-the-comment-on-atypical-retroperitoneal-fibrosis-associated-0rghLm0RbF